Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug
CSL Limited retain rights to clazakizumab in end-stage kidney disease. Eli Lilly gets rights to…
Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug
CSL Limited retain rights to clazakizumab in end-stage kidney disease. Eli Lilly gets rights to the the IL-6-blocking antibody in other indications that could put it in competition with Novo Nordisk and Novartis. The post Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug appeared first on MedCity News.
Medicaid Managed Care Reporting and Transparency: Managed Care Program Annual Reports
This brief describes the Managed Care Program Annual Report (MCPAR), a relatively new, comprehensive report on state Medicaid managed care programs that includes plan-level data. It is used with other managed care reports to improve state and federal managed care program monitoring, oversight, and transparency.
Healthcare’s AI Obsession Is Missing the Point on Nursing Shortages
Healthcare leaders must resist using AI as a substitute for staffing. Instead, invest in workforce optimization technology that empowers nurses, creates flexible pathways, and addresses the systemic issues driving burnout. The post Healthcare’s AI Obsession Is Missing the Point on Nursing Shortages appeared first on MedCity News.
Addressing the 58% Launch Failure Rate: Accelerating Market Access Through Intelligent Decision-Making
Here are some of the structural and strategic causes behind that failure rate, and ways to improve launch outcomes. The post Addressing the 58% Launch Failure Rate: Accelerating Market Access Through Intelligent Decision-Making appeared first on MedCity News.
Red and Blue States Alike Want To Limit AI in Insurance. Trump Wants To Limit the States.
It’s the rare policy question that unites Republican Gov. Ron DeSantis of Florida and the Democratic-led Maryland government against President Donald Trump and Gov. Gavin Newsom of California: How should health insurers use AI? Regulating artificial intelligence, especially its use by health insurers, is becoming a politically divisive topic, and it’s scrambling traditional partisan lines….
Wyoming Wants To Make Its Five-Year Federal Rural Health Funding Last ‘Forever’
Wyoming officials say they have a plan to make five years of upcoming grants from a new $50 billion federal rural health program last “forever.” The state could tackle rural health issues long into the future by investing its awards from the Rural Health Transformation Program, the director of Wyoming’s health department, Stefan Johansson, told…
How has private equity hospital ownership impact the quality of labor & delivery care?
The number of hospitals owned by private equity (PE) firms has increased in recent years. One key question is how increased PE ownership has impact quality of care. To answer the question, a Jiao 2025 Health Services Research paper used claims Medicaid claims data–specifically data from the Transformed Medicaid Statistical Information System (T-MSIS) and Medicaid…
Daffodil Health Secures $16.3M for Health Plan Administration Platform
Daffodil’s Series A round was led by Flare Capital Partners, with participation from LRVHealth and Maverick Ventures. The post Daffodil Health Secures $16.3M for Health Plan Administration Platform appeared first on MedCity News.
Ocular Therapeutix Eyes FDA Filing After Wet AMD Drug Tops Regeneron’s Eylea in Phase 3 Test
In the first of two Phase 3 tests, Ocular Therapeutix’s Axpaxli met the main goal of helping maintain vision in patients with the wet form of age-related macular degeneration. The Ocular drug was compared to Eylea, a blockbuster wet AMD drug marketed by Regeneron Pharmaceuticals and Bayer. The post Ocular Therapeutix Eyes FDA Filing After…
Regulatory Innovation as a Catalyst: How New Compliance Strategies Are Speeding Up Healthcare Technology Adoption
Regulatory frameworks are no longer simply gatekeepers of safety; they increasingly help ensure that new technologies are easier to understand, simpler to use, and more compatible with real-world healthcare settings. The post Regulatory Innovation as a Catalyst: How New Compliance Strategies Are Speeding Up Healthcare Technology Adoption appeared first on MedCity News.
